Exactly Also, one single secondary going to Amarin should suffice to uphold the patent if I understood correctly what the Harvard lawyer and others said. So if that is correct, then this ruling has real issues.
About the 3 to 2 score, I will not even get into the gaps that I see on the other 3 points that she gave to generics as I see weaknesses as well. The above (one single secondary for Amarin) should be sufficient to prevent ruling to invalidate the patents.
News 
Market Data 
Discover 
